The Akt inhibitor triciribine sensitizes prostate carcinoma cells to TRAIL‐induced apoptosis

Alexandra Dieterle(University of Tübingen), Björn Stork(Düsseldorf University Hospital)
International Journal of Cancer
February 18, 2009
Cited by 42


Related Papers